Metamorphic proteins at the basis of human autophagy initiation and lipid transfer.

autophagy autophagy initiation lipid transfer membrane-contact site metabolism protein metamorphosis

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
15 Jun 2023
Historique:
received: 31 08 2022
revised: 23 02 2023
accepted: 27 04 2023
medline: 19 6 2023
pubmed: 21 5 2023
entrez: 20 5 2023
Statut: ppublish

Résumé

Autophagy is a conserved intracellular degradation pathway that generates de novo double-membrane autophagosomes to target a wide range of material for lysosomal degradation. In multicellular organisms, autophagy initiation requires the timely assembly of a contact site between the ER and the nascent autophagosome. Here, we report the in vitro reconstitution of a full-length seven-subunit human autophagy initiation supercomplex built on a core complex of ATG13-101 and ATG9. Assembly of this core complex requires the rare ability of ATG13 and ATG101 to switch between distinct folds. The slow spontaneous metamorphic conversion is rate limiting for the self-assembly of the supercomplex. The interaction of the core complex with ATG2-WIPI4 enhances tethering of membrane vesicles and accelerates lipid transfer of ATG2 by both ATG9 and ATG13-101. Our work uncovers the molecular basis of the contact site and its assembly mechanisms imposed by the metamorphosis of ATG13-101 to regulate autophagosome biogenesis in space and time.

Identifiants

pubmed: 37209685
pii: S1097-2765(23)00321-0
doi: 10.1016/j.molcel.2023.04.026
pii:
doi:

Substances chimiques

Autophagy-Related Proteins 0
Membrane Proteins 0
Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2077-2090.e12

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Anh Nguyen (A)

Max-Planck Institute for Multidisciplinary Sciences, Laboratory of Biochemistry of Signal Dynamics, Göttingen, Germany.

Francesca Lugarini (F)

Max-Planck Institute for Multidisciplinary Sciences, Laboratory of Biochemistry of Signal Dynamics, Göttingen, Germany.

Céline David (C)

Institute of Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.

Pouya Hosnani (P)

Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany; University Medical Centre Göttingen, Department of Cellular Biochemistry, Göttingen, Germany.

Çağla Alagöz (Ç)

Max-Planck Institute for Multidisciplinary Sciences, Laboratory of Biochemistry of Signal Dynamics, Göttingen, Germany.

Annabelle Friedrich (A)

Institute of Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.

David Schlütermann (D)

Institute of Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.

Barbora Knotkova (B)

Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany; University Medical Centre Göttingen, Department of Cellular Biochemistry, Göttingen, Germany.

Anoshi Patel (A)

Max-Planck Institute for Multidisciplinary Sciences, Laboratory of Biochemistry of Signal Dynamics, Göttingen, Germany.

Iwan Parfentev (I)

Max-Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry, Göttingen, Germany.

Henning Urlaub (H)

Max-Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry, Göttingen, Germany; University Medical Centre Göttingen, Institute of Clinical Chemistry, Bioanalytics Group, Göttingen, Germany.

Michael Meinecke (M)

Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany; University Medical Centre Göttingen, Department of Cellular Biochemistry, Göttingen, Germany.

Björn Stork (B)

Institute of Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.

Alex C Faesen (AC)

Max-Planck Institute for Multidisciplinary Sciences, Laboratory of Biochemistry of Signal Dynamics, Göttingen, Germany. Electronic address: alex.faesen@mpinat.mpg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH